 SAN MATEO, Calif. and CAMBRIDGE, Mass., March 26, 2021 GLOBE NEWSWIRE -- Kronos Bio, Inc. Nasdaq: KRON, a company dedicated to transforming the lives of those affected by cancer, today announced the appointment of Taiyin Yang, Ph.D., to the companys board of directors. Dr. Yang has more than four decades of experience in developing and manufacturing medicines in a variety of therapeutic categories. Additionally, Jakob Loven has notified the company that he will not stand for re-election at the companys 2021 Annual Meeting of Stockholders. 